SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-090923
Filing Date
2024-08-19
Accepted
2024-08-19 17:47:00
Documents
1
Group Members
BECKTON CORP.ICAHN CAPITAL LPICAHN ENTERPRISES G.P. INC.ICAHN ENTERPRISES HOLDINGS L.P.ICAHN OFFSHORE LPICAHN ONSHORE LPICAHN PARTNERS LPICAHN PARTNERS MASTER FUND LPIPH GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2421713d3_sc13da.htm SC 13D/A 20001
  Complete submission text file 0001104659-24-090923.txt   22445
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 241221999
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ICAHN ENTERPRISES L.P. 16690 COLLINS AVE., PH-1 SUNNY ISLES BEACH FL 33160
Business Address C/O ICAHN ENTERPRISES L.P. 16690 COLLINS AVE., PH-1 SUNNY ISLES BEACH FL 33160 305-422-4145
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000
(CF Office: CF)